![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1523249
±âħ¾à ½ÃÀå º¸°í¼ : µ¿Çâ, ¿¹Ãø ¹× °æÀï ºÐ¼®(-2030³â)Cough Remedy Market Report: Trends, Forecast and Competitive Analysis to 2030 |
±âħ¾àÀÇ µ¿Çâ°ú Àü¸Á
¼¼°è ±âħ¾à ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö 3.4%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î 2030³â±îÁö ¾à 13¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀº ³ëÀÎ Àα¸ÀÇ ±ÞÁõ, ±âħ¾à¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, OTC Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ÀÔ´Ï´Ù. ¼¼°è ±âħ¾à ½ÃÀåÀº ¼Ò¸Å ¾à±¹, º´¿ø ¾à±¹ ¹× ¿Â¶óÀÎ ¾à±¹ ½ÃÀå¿¡¼ÀÇ ±âȸ·Î ÀÎÇØ ¹Ì·¡°¡ À¯¸ÁÇÕ´Ï´Ù.
ºÎ¹®º° ±âħ¾à
±âħ¾à ¼¼°è ½ÃÀå¿¡ ´ëÇØ Á¦Ç° À¯Çüº°, ¿¬·É´ëº°, À¯Åë ä³Îº°, Áö¿ªº° ¿¹ÃøÀ» Á¦°øÇÕ´Ï´Ù.
±âħ¾à ½ÃÀå ÀλçÀÌÆ®
LucintelÀÇ ¿¹Ãø¿¡ µû¸£¸é, È£Èí±â Áúȯ Áõ°¡·Î ÀÎÇØ °Å´ãÁ¦´Â ¿¹Ãø ±â°£ µ¿¾È °¡Àå Å« ºÎ¹®À¸·Î ³²À» °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.
ÀÌ ½ÃÀå¿¡¼ º´¿ø¾à±¹Àº º´¿ø¾à±¹À» ¼±È£ÇÏ´Â ¿Ü·¡È¯ÀÚ ¹× ÀÔ¿øÈ¯ÀÚ Áõ°¡·Î ÀÎÇØ °¡Àå Å« ºÎ¹®À¸·Î ³²À» °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.
¾Æ½Ã¾ÆÅÂÆò¾çÀº ³ëÀÎ Àα¸ Áõ°¡¿Í »ç¶÷µéÀÇ °Ç° °ü¸®¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
Q1. ½ÃÀå ±Ô¸ð :
A1. ¼¼°è ±âħ¾à ½ÃÀåÀº 2030³â±îÁö ¾à 13¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
Q2. ½ÃÀå ¼ºÀå ¿¹ÃøÀº ´ÙÀ½°ú °°½À´Ï´Ù.
A2. ¼¼°è ±âħ¾à ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) 3.4%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
Q3. ½ÃÀå ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ÃËÁø¿äÀÎÀº ´ÙÀ½°ú °°½À´Ï´Ù.
A3. ÀÌ ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀº ³ë·É Àα¸ÀÇ ±ÞÁõ, ±âħ¾à¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, OTC Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ÀÔ´Ï´Ù.
Q4. ½ÃÀåÀÇ ÁÖ¿ä ºÎ¹®Àº ´ÙÀ½°ú °°½À´Ï´Ù.
A4. ±âħ¾à ½ÃÀåÀÇ ¹Ì·¡´Â ¼Ò¸Å ¾à±¹, º´¿ø ¾à±¹, ¿Â¶óÀÎ ¾à±¹ ½ÃÀå¿¡¼ÀÇ ±âȸ·Î ÀÎÇØ ´õ¿í À¯¸ÁÇÕ´Ï´Ù.
Q5. ½ÃÀå ÁÖ¿ä ±â¾÷Àº ´ÙÀ½°ú °°½À´Ï´Ù.
A5. ±âħ¾à ÁÖ¿ä ±â¾÷Àº ´ÙÀ½°ú °°½À´Ï´Ù.
Q6. ÇâÈÄ °¡Àå Å« ½ÃÀå ºÎ¹®Àº ´ÙÀ½°ú °°½À´Ï´Ù.
A6. LucintelÀº È£Èí±â Áúȯ Áõ°¡·Î ÀÎÇØ °Å´ãÁ¦°¡ ¿¹Ãø ±â°£ µ¿¾È °¡Àå Å« ºÎ¹®À¸·Î ³²À» °ÍÀ¸·Î ¿¹»óÇϰí ÀÖ½À´Ï´Ù.
Q7. ½ÃÀå¿¡¼ ÇâÈÄ 5³â°£ °¡Àå Å« ½ÃÀåÀÌ µÉ °ÍÀ¸·Î ¿¹»óµÇ´Â Áö¿ªÀº ¾îµðÀԴϱî?
A7.APAC Áö¿ªÀº ³ëÀÎ Àα¸ Áõ°¡¿Í »ç¶÷µéÀÇ °Ç° °ü¸®¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
Q8. º¸°í¼ »ç¿ëÀÚ Á¤Àǰ¡ °¡´ÉÇմϱî?
A8. ³×. LucintelÀº Ãß°¡ ºñ¿ë¾øÀÌ 10%ÀÇ »ç¿ëÀÚ Á¤ÀǸ¦ Á¦°øÇÕ´Ï´Ù.
Cough Remedy Trends and Forecast
The future of the global cough remedy market looks promising with opportunities in the retail pharmacy, hospital pharmacy, and online pharmacy markets. The global cough remedy market is expected to reach an estimated $1.3 billion by 2030 with a CAGR of 3.4% from 2024 to 2030. The major drivers for this market are surge in geriatric population, increasing awareness about cough remedies, and growing demand for over-the-counter (OTC) products.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Cough Remedy by Segment
The study includes a forecast for the global cough remedy by product type, age group, distribution channel, and region.
List of Cough Remedy Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies cough remedy companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the cough remedy companies profiled in this report include-
Cough Remedy Market Insights
Lucintel forecasts that expectorant will remain the largest segment over the forecast period due to increasing incidences of respiratory diseases.
Within this market, hospital pharmacy will remain the largest segment due to rise in number of outpatients and inpatients preferring hospital pharmacy.
APAC is expected to witness the highest growth over the forecast period due to rising geriatric population and growing healthcare awareness among people in the region.
Features of the Global Cough Remedy Market
Market Size Estimates: Cough remedy market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Cough remedy market size by product type, age group, distribution channel, and region in terms of value ($B).
Regional Analysis: Cough remedy market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different product types, age group, distribution channel, and regions for the cough remedy market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the cough remedy market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
FAQ
Q1. What is the cough remedy market size?
Answer: The global cough remedy market is expected to reach an estimated $1.3 billion by 2030.
Q2. What is the growth forecast for cough remedy market?
Answer: The global cough remedy market is expected to grow with a CAGR of 3.4% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the cough remedy market?
Answer: The major drivers for this market are surge in geriatric population, increasing awareness about cough remedies, and growing demand for over-the-counter (OTC) products.
Q4. What are the major segments for cough remedy market?
Answer: The future of the cough remedy market looks promising with opportunities in the retail pharmacy, hospital pharmacy, and online pharmacy markets.
Q5. Who are the key cough remedy market companies?
Answer: Some of the key cough remedy companies are as follows:
Q6. Which cough remedy market segment will be the largest in future?
Answer: Lucintel forecasts that expectorant will remain the largest segment over the forecast period due to increasing incidences of respiratory diseases.
Q7. In cough remedy market, which region is expected to be the largest in next 5 years?
Answer: APAC is expected to witness the highest growth over the forecast period due to rising geriatric population and growing healthcare awareness among people in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.